BeOne Medicines Ltd. Stockholders' Equity 2013-2026 | ONC
What is stockholders' equity?
Stockholders' equity can be defined as total assets minus total liabilities, representing the owners' residual interest in the company after all debts are paid.
What is BeOne Medicines Ltd.'s current stockholders' equity?
BeOne Medicines Ltd. (ONC) annual stockholders' equity for 2025 was $4.36B, a 30.88% increase from 2024. BeOne Medicines Ltd. stockholders' equity for the quarter ending March 31, 2026 was $4.76B.
What was BeOne Medicines Ltd.'s stockholders' equity in 2024?
BeOne Medicines Ltd. annual stockholders' equity for 2024 was $3.33B, a 5.80% decline from 2023.
What was BeOne Medicines Ltd.'s stockholders' equity in 2023?
BeOne Medicines Ltd. annual stockholders' equity for 2023 was $3.54B, a 19.30% decline from 2022.
What is BeOne Medicines Ltd.'s 5-year stockholders' equity CAGR?
BeOne Medicines Ltd. stockholders' equity grew at a compound annual growth rate (CAGR) of 2.42% from FY2020 to FY2025, going from $3.87B to $4.36B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $4.36B | +30.9% | 10-K |
| FY2024 | $3.33B | -5.8% | 10-K |
| FY2023 | $3.54B | -19.3% | 10-K |
| FY2022 | $4.38B | -28.5% | 10-K |
| FY2021 | $6.13B | +58.5% | 10-K |
| FY2020 | $3.87B | +311.4% | 10-K |
| FY2019 | $940.5M | -46.4% | 10-K |
| FY2018 | $1.75B | +156.3% | 10-K |
| FY2017 | $684.2M | +93.9% | 10-K |
| FY2016 | $352.9M | +446.8% | 10-K |
| FY2015 | $-101.8M | -91.9% | 10-K |
| FY2014 | $-53.0M | -43.5% | 10-K |
| FY2013 | $-37.0M | - | 10-K |